• Disclaimer
• SiteMap
• Home

• about us
  • Corporate Profile
  • Board of Directors
• technology
  • GIPET®
  • Strategic Partnering
• portfolio
  • Product Pipeline
  • Strategic Partnering
  • Orazol™ (Breast Cancer)
  • Orazol™ (Bone Metastases)
  • Almerol™ (MER-103)
  • Acyline (MER-104)
  • MER-102
• investor relations
  • Corporate Profile
  • Share Information
  • Annual Reports /
    Financial Information
  • Financial Calendar
  • Investor Alert
  • Regulatory News
  • Corporate Governance
  • Analyst Coverage
  • Advisors and Registrars
  • Ownership Summary
  • Rule 26 Information
• media
• contact

Annual Reports / Financial Information

• Print page
• Email page

2011 Annual Report

Interim Results for the six months ended 30 June 2011

2010 Annual Report

Preliminary Results for the year ended 31 December 2010

Interim Results for the six months ended 30 June 2010

2009 Annual Report

Interim Results for the six months ended 30 June 2009

2008 Annual Report

Interim Results for the six months ended 30 June 2008

2007 Annual Report

Constitutional Documents

To download the company's Memorandum of Association, please
click here (54KB)

To download the company's Articles of Association, please click here (350KB)

Admission Document

Admission Document for Merrion Pharmaceuticals, available in PDF format.